Key result
Aspirin inhibited collagen-induced aggregation in gel-filtered rat platelets regardless of collagen concentration, but this inhibitory effect decreased in a plasma dose-dependent manner when plasma was added.
Answers are grounded in this paper and cite their sources.
Plasma may attenuate aspirin's antiplatelet effect; leaves open the role of plasma factors in modulating aspirin response in vivo.
We investigated the inhibitory effect of aspirin on collagen induced platelet aggregation using rat PRP (platelet rich plasma) and GFP (gel filtered platelet). In the case of PRP, low concentration of collagen induced aggregation was inhibited by aspirin but when collagen concentration was increased, aggregation was observed in spite of the presence of aspirin. On the contrary, in the case of GFP, collagen induced aggregation was always inhibited by aspirin regardless of the collagen concentration. But when rat plasma was added to GFP, the inhibitory effect of aspirin on collagen induced aggregation decreased in a plasma dose dependent manner. These studies suggest that plasma factor(s) are essential for the aspirin noninhibited aggregation which is induced by high concentration of collagen.
No takes yet. Share an insight, caveat, or question.
Gotō et al. (1988) studied Platelet aggregation. Aspirin vs. Control was evaluated on Collagen-induced platelet aggregation. Aspirin inhibited collagen-induced aggregation in gel-filtered rat platelets regardless of collagen concentration, but this inhibitory effect decreased in a plasma dose-dependent manner when plasma was added.
Synapse has enriched 10 related papers. Consider them for comparative context: